
|Articles|June 28, 2002
FDA Issues Comprehensive List of Guidance Documents
Author(s)BioPharm International Editors
28 JUNE - Comprehensive List of Guidance Documents http://www.fda.gov/cder/guidance/guidlist.pdf
Advertisement
FDA has issued a Comprehensive List of Guidance Documents, available at:www.fda.gov/cder/guidance/guidlist.pdf
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5




